Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Read More

Overview

Feature Articles

Latest Vaccine News and Research

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

Global economic recovery at risk due to COVID-19 vaccine inequity

Global economic recovery at risk due to COVID-19 vaccine inequity

Research uncovers an unexpected role for immune T cells in protection against malaria

Research uncovers an unexpected role for immune T cells in protection against malaria

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Researchers use mass spectrometry to study immunogenic SARS-CoV-2 epitopes

Researchers use mass spectrometry to study immunogenic SARS-CoV-2 epitopes

Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

CDC monitoring over 200 individuals possibly exposed to monkeypox

CDC monitoring over 200 individuals possibly exposed to monkeypox

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

KHN’s ‘What the Health?’: Delta changes the covid conversation

KHN’s ‘What the Health?’: Delta changes the covid conversation

Study in France suggests high efficacy of mRNA vaccines against SARS-CoV-2 variants of concern

Study in France suggests high efficacy of mRNA vaccines against SARS-CoV-2 variants of concern

Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2

Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2

Finding most promising targets for pan-coronavirus drugs

Finding most promising targets for pan-coronavirus drugs

Big leagues balk at endorsing vaccination

Big leagues balk at endorsing vaccination

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Two-dose regimen of mRNA vaccines provides protection against Alpha and Beta variants in France

Two-dose regimen of mRNA vaccines provides protection against Alpha and Beta variants in France

Study evaluates ICU workers' mental health during the COVID-19 pandemic

Study evaluates ICU workers' mental health during the COVID-19 pandemic

Older people appear to have diminished antibody response after COVID-19 vaccination

Older people appear to have diminished antibody response after COVID-19 vaccination